Wafaa K. Makarm
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Wafaa K. Makarm has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- RababS. Zaghlol
Rheumatology and rehabilitation Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt
6 shared publications - Doaa Mohamed Sharaf
Doaa Sharaf, Rheumatology and Rehabilitation Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt
2 shared publications - Ghada Aboelsaud Dawaa
Rheumatology and rehabilitation Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt
2 shared publications - Lobna Ismaeil Kotb
Rheumatology and rehabilitation Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt
2 shared publications - Dalia S. Fahmi
Rheumatology and rehabilitation Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt
1 shared publication - Manar G. Gebriel
Medical Microbiology and Immunology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt
1 shared publication
Latest Publications
- 5 November 2025
- Published by Springer Nature in Clinical Rheumatology
- Vol. 45 (1) , 383-393
Evaluation of predictors and clinical outcome after tapering of chronic systemic corticosteroids in Behçet’s disease patients
Objectives To identify predictive factors for successful oral glucocorticoid (GC) tapering in a longitudinal cohort of Behçet’s disease (BD) patients in remission or with low disease activity, and to evaluate post-tapering outcomes over a one-year period. Methods This is an observational longitudinal cohort study, focusing on BD patients who began GC tapering and achieved remission or low disease activity. Patients who achieved sustained remission or low disease activity while maintaining a prednisone dose of ≤ 5 mg/day were classified as "successful tapering," while those who failed to achieve this outcome were classified as "failed tapering". A regression model was used to identify predictors of successful GC tapering to ≤ 5 mg/day. Results A total of 72 BD patients were enrolled and followed-up for 12 months. Multivariate analysis confirmed that short disease duration (odds ratio (OR) = 0.395, 95% CI: 0.197–0.794, p = 0.009), low activity at disease onset (OR = 0.177, 95% CI: 0. 037–0.846, p = 0.03), low severity score for BD at baseline (OR = 0.092, 95% CI:.010–0.876, p = 0.038), and low C-reactive protein value at baseline (OR = 0.186, 95% CI:0.039–0.883, p = 0.034) were the predictors for successful GC tapering. Conclusion The independent factors linked to success in tapering glucocorticoid in BD were shorter disease duration, low activity at disease onset, low severity score at baseline, and low C-reactive protein value. These findings suggest that they could be used in clinical settings to identify tapering candidates. Key Points •1- Behcet disease is a challenge to treat and usually necessitates a multidisciplinary strategy •2- Glucocorticoids have been used to treat almost all disease lesions •3- Long-term Glucocorticoids use is associated with adverse events •4- The independent factors linked to success in tapering glucocorticoid in Behcet disease were short disease duration, low activity at disease onset, low severity score at baseline, and low C-reactive protein value.
- 5 November 2025
- Published by Springer Nature in Clinical Rheumatology
- Vol. 45 (1) , 383-393
Evaluation of predictors and clinical outcome after tapering of chronic systemic corticosteroids in Behçet’s disease patients
Objectives To identify predictive factors for successful oral glucocorticoid (GC) tapering in a longitudinal cohort of Behçet’s disease (BD) patients in remission or with low disease activity, and to evaluate post-tapering outcomes over a one-year period. Methods This is an observational longitudinal cohort study, focusing on BD patients who began GC tapering and achieved remission or low disease activity. Patients who achieved sustained remission or low disease activity while maintaining a prednisone dose of ≤ 5 mg/day were classified as "successful tapering," while those who failed to achieve this outcome were classified as "failed tapering". A regression model was used to identify predictors of successful GC tapering to ≤ 5 mg/day. Results A total of 72 BD patients were enrolled and followed-up for 12 months. Multivariate analysis confirmed that short disease duration (odds ratio (OR) = 0.395, 95% CI: 0.197–0.794, p = 0.009), low activity at disease onset (OR = 0.177, 95% CI: 0. 037–0.846, p = 0.03), low severity score for BD at baseline (OR = 0.092, 95% CI:.010–0.876, p = 0.038), and low C-reactive protein value at baseline (OR = 0.186, 95% CI:0.039–0.883, p = 0.034) were the predictors for successful GC tapering. Conclusion The independent factors linked to success in tapering glucocorticoid in BD were shorter disease duration, low activity at disease onset, low severity score at baseline, and low C-reactive protein value. These findings suggest that they could be used in clinical settings to identify tapering candidates. Key Points •1- Behcet disease is a challenge to treat and usually necessitates a multidisciplinary strategy •2- Glucocorticoids have been used to treat almost all disease lesions •3- Long-term Glucocorticoids use is associated with adverse events •4- The independent factors linked to success in tapering glucocorticoid in Behcet disease were short disease duration, low activity at disease onset, low severity score at baseline, and low C-reactive protein value.
- Open Access
- 30 October 2023
- Published by Springer Nature in Egyptian Rheumatology and Rehabilitation
- Vol. 50 (1) , 1
Correction: Risk assessment score for adverse pregnancy outcome in systemic lupus erythematosus patients
- 30 October 2023
- Published by Springer Nature in Egyptian Rheumatology and Rehabilitation
- Vol. 50 (1) , 1
Open AccessCorrection: Risk assessment score for adverse pregnancy outcome in systemic lupus erythematosus patients
- Open Access
- 24 October 2022
- Published by Springer Nature in Egyptian Rheumatology and Rehabilitation
- Vol. 49 (1) , 1-10
Burden of enthesitis on the quality of life and work productivity in psoriatic arthritis patients
Background: Psoriatic arthritis (PsA) which affects 6–42% of psoriasis patients is the most common extra-cutaneous manifestation of the psoriasis disease. Enthesitis may be considered as a sign of increased disease burden due to its association with several clinical aspects. Therefore, the aim of the study was to investigate the effect of clinical enthesitis on quality of life and work productivity in PsA patients. Results: Enthesitis was detected in 50% of patients. There was statistically significant difference between the studied groups as regard disease activity index for psoriatic arthritis (DAPSA) score, psoriatic arthritis impact of the disease 12 (PsAID-12), Health Assessment Questionnaire disability index (HAQ-DI), and Spondyloarthritis Research Consortium of Canada index (SPARCC) with higher mean score in patients with enthesitis. The majority of patients with enthesitis had a higher percentage of impairment in daily activities (95.5%) than those without enthesitis (38.6%), as well as a statistically significant positive correlation between SPARCC index and both work absenteeism and work productivity loss. Furthermore, enthesitis in both the upper and lower sites was related with worse quality of life (36.4%) and higher work impairment (45.5%) compared to patients with enthesitis in either the upper or lower sites alone. Conclusion: Enthesitis was a frequent complaint among PsA patients. PsA patients with enthesitis had a significant disease burden regardless of enthesitis location, and patients with enthesitis in both the upper and lower sites have a worse quality of life and a higher work impairment.
- 24 October 2022
- Published by Springer Nature in Egyptian Rheumatology and Rehabilitation
- Vol. 49 (1) , 1-10
Open AccessBurden of enthesitis on the quality of life and work productivity in psoriatic arthritis patients
Background: Psoriatic arthritis (PsA) which affects 6–42% of psoriasis patients is the most common extra-cutaneous manifestation of the psoriasis disease. Enthesitis may be considered as a sign of increased disease burden due to its association with several clinical aspects. Therefore, the aim of the study was to investigate the effect of clinical enthesitis on quality of life and work productivity in PsA patients. Results: Enthesitis was detected in 50% of patients. There was statistically significant difference between the studied groups as regard disease activity index for psoriatic arthritis (DAPSA) score, psoriatic arthritis impact of the disease 12 (PsAID-12), Health Assessment Questionnaire disability index (HAQ-DI), and Spondyloarthritis Research Consortium of Canada index (SPARCC) with higher mean score in patients with enthesitis. The majority of patients with enthesitis had a higher percentage of impairment in daily activities (95.5%) than those without enthesitis (38.6%), as well as a statistically significant positive correlation between SPARCC index and both work absenteeism and work productivity loss. Furthermore, enthesitis in both the upper and lower sites was related with worse quality of life (36.4%) and higher work impairment (45.5%) compared to patients with enthesitis in either the upper or lower sites alone. Conclusion: Enthesitis was a frequent complaint among PsA patients. PsA patients with enthesitis had a significant disease burden regardless of enthesitis location, and patients with enthesitis in both the upper and lower sites have a worse quality of life and a higher work impairment.
- Open Access
- 3 June 2022
- Published by Springer Nature in Egyptian Rheumatology and Rehabilitation
- Vol. 49 (1) , 1-11
Risk assessment score for adverse pregnancy outcome in systemic lupus erythematosus patients
Background: Systemic lupus is a chronic autoimmune multisystem disease that mainly affects females of childbearing age. SLE still possesses risks during pregnancy that lead to poor maternal and fetal outcomes. The objectives of the study were to identify factors associated with unfavorable pregnancy outcomes and develop a predictive risk score for adverse pregnancy outcomes in patients with SLE. Results: The main predictive factors associated with adverse pregnancy outcomes among lupus patients in multiple linear regression were an absence of remission for at least 6 months before conception, preexisting lupus nephritis, active disease at conception, C3 hypocomplementemia, and antiphospholipid antibody syndrome. Each predictor is assigned a weighted point score, and the sum of points represents the risk score. The area under the receiver operating characteristic curve (ROC) was 0.948 (95% confidence interval, 0.908–0.988), suggesting that the score had strong discriminatory power for adverse pregnancy outcomes. Conclusions: In this study, a predictive model with a risk score classification for adverse pregnancy outcomes in SLE patients was developed. This could help rheumatologists identify high-risk pregnant patients for better disease monitoring and management, resulting in better maternal/fetal outcomes.
- 3 June 2022
- Published by Springer Nature in Egyptian Rheumatology and Rehabilitation
- Vol. 49 (1) , 1-11
Open AccessRisk assessment score for adverse pregnancy outcome in systemic lupus erythematosus patients
Background: Systemic lupus is a chronic autoimmune multisystem disease that mainly affects females of childbearing age. SLE still possesses risks during pregnancy that lead to poor maternal and fetal outcomes. The objectives of the study were to identify factors associated with unfavorable pregnancy outcomes and develop a predictive risk score for adverse pregnancy outcomes in patients with SLE. Results: The main predictive factors associated with adverse pregnancy outcomes among lupus patients in multiple linear regression were an absence of remission for at least 6 months before conception, preexisting lupus nephritis, active disease at conception, C3 hypocomplementemia, and antiphospholipid antibody syndrome. Each predictor is assigned a weighted point score, and the sum of points represents the risk score. The area under the receiver operating characteristic curve (ROC) was 0.948 (95% confidence interval, 0.908–0.988), suggesting that the score had strong discriminatory power for adverse pregnancy outcomes. Conclusions: In this study, a predictive model with a risk score classification for adverse pregnancy outcomes in SLE patients was developed. This could help rheumatologists identify high-risk pregnant patients for better disease monitoring and management, resulting in better maternal/fetal outcomes.
- 1 January 2022
- Published by Bentham Science Publishers Ltd. in Current Rheumatology Reviews
- Vol. 18 (3) , 257-265
Functional Disability among Systemic Sclerosis Patients: Relation to Disease Characteristics and Quality of Life Parameters
Background: Disability in patients with scleroderma (SSc) has been associated with poor health-related quality of life (HRQoL) in all dimensions, including physical, psychological, and social dimensions. Objective: This study was conducted to examine different factors that may be associated with functional disability and poor HRQoL, with the aim of targeting these factors in the future to improve physical activity, functional outcomes, and HRQoL. Methods: A single-center cross-sectional study was conducted on 38 patients with SSc to compare characteristics between patients with and without disability using the Health Assessment Questionnaire Disability Index (HAQ-DI). Quality of life was assessed using the Short Form-36 (SF-36). Linear regressions were performed to examine variables contributing to functional disability. Results: Almost 65.78% (n 25) of patients in the study group reported functional disability. The presence of functional disability was associated with reduced HRQoL, as reflected by physical function (P = 0.0001), physical role (P = 0.016), bodily pain (P = 0.001), general health (P = 0.002), social functional (P = 0.002), emotional role (P = 0.042), and mental health (P = 0.025) domains of the SF-36 score. Multiple linear regression indicated that the main predictive factors associated with HAQ-DI were the modified I land Mobility in Scleroderma, modified Rodnan skin score, Distance walked in 6 minutes, BOrg dyspnea index, and SAturation of oxygen at 6 minutes (DIBOSA), and Fatigue Severity Scale among patients with SSc. Conclusion: In patients with SSc, recognizing the relationships between clinical findings and functional disability will allow the development of further management strategies to minimize disease severity and enhance HRQoL.
- 1 January 2022
- Published by Bentham Science Publishers Ltd. in Current Rheumatology Reviews
- Vol. 18 (3) , 257-265
Functional Disability among Systemic Sclerosis Patients: Relation to Disease Characteristics and Quality of Life Parameters
Background: Disability in patients with scleroderma (SSc) has been associated with poor health-related quality of life (HRQoL) in all dimensions, including physical, psychological, and social dimensions. Objective: This study was conducted to examine different factors that may be associated with functional disability and poor HRQoL, with the aim of targeting these factors in the future to improve physical activity, functional outcomes, and HRQoL. Methods: A single-center cross-sectional study was conducted on 38 patients with SSc to compare characteristics between patients with and without disability using the Health Assessment Questionnaire Disability Index (HAQ-DI). Quality of life was assessed using the Short Form-36 (SF-36). Linear regressions were performed to examine variables contributing to functional disability. Results: Almost 65.78% (n 25) of patients in the study group reported functional disability. The presence of functional disability was associated with reduced HRQoL, as reflected by physical function (P = 0.0001), physical role (P = 0.016), bodily pain (P = 0.001), general health (P = 0.002), social functional (P = 0.002), emotional role (P = 0.042), and mental health (P = 0.025) domains of the SF-36 score. Multiple linear regression indicated that the main predictive factors associated with HAQ-DI were the modified I land Mobility in Scleroderma, modified Rodnan skin score, Distance walked in 6 minutes, BOrg dyspnea index, and SAturation of oxygen at 6 minutes (DIBOSA), and Fatigue Severity Scale among patients with SSc. Conclusion: In patients with SSc, recognizing the relationships between clinical findings and functional disability will allow the development of further management strategies to minimize disease severity and enhance HRQoL.
- Open Access
- 24 June 2021
- Published by Wiley in International Journal of Microbiology
- Vol. 2021, 1-7
Altered Profile of Fecal Microbiota in Newly Diagnosed Systemic Lupus Erythematosus Egyptian Patients
Background. Dysbiosis of gut microbiota could promote autoimmune disorders including systemic lupus erythematosus (SLE). Clarifying this point would be of great importance in understanding the pathogenesis and hence the development of new strategies for SLE treatment. Aim. This study aimed to determine the fecal microbiota profile in newly diagnosed SLE patients compared to healthy subjects and to investigate the correlation of this profile with disease activity. Methods. Newly diagnosed SLE patients who fulfilled at least four of the American College of Rheumatology (ACR) criteria were enrolled during the study period. Patients with lupus were matched to healthy subjects. SLE activity was evaluated using the Systemic Lupus Disease Activity Index (SLEDAI-2K). Fresh fecal samples were collected from each subject. Genomic DNA was extracted from fecal samples. Quantitative real-time PCR was applied for quantitation of Firmicutes phylum, Bacteroidetes phylum, and Lactobacillus genus in comparison to the total fecal microbiota. Results of patients’ samples were compared to those of healthy subjects and were correlated to patients’ SLEDAI-2K score. Results. Twenty SLE patients’ samples were compared with 20 control samples. There was a significant alteration in SLE patients’ gut microbiota. A significantly lower ( ) Firmicutes/Bacteroidetes (F/B) ratio in SLE patients (mean ratio: 0.66%) compared to healthy subjects (mean ratio: 1.79%) was found. Lactobacillus showed a significant decrease in SLE patients ( ) in comparison to healthy controls. An inverse significant correlation between SLEDAI-2K scores for disease activity and F/B ratio (r = −0.451; ) was found. However, an inverse nonsignificant correlation between SLEDAI-2K scores for disease activity and Lactobacillus (r = −0.155; ) was detected. Conclusion. Compared to healthy controls, recently diagnosed SLE Egyptian patients have an altered fecal microbiota profile with significant lowering of both F/B ratio and Lactobacillus abundance, which is weakly correlated with disease activity.
- 24 June 2021
- Published by Wiley in International Journal of Microbiology
- Vol. 2021, 1-7
Open AccessAltered Profile of Fecal Microbiota in Newly Diagnosed Systemic Lupus Erythematosus Egyptian Patients
Background. Dysbiosis of gut microbiota could promote autoimmune disorders including systemic lupus erythematosus (SLE). Clarifying this point would be of great importance in understanding the pathogenesis and hence the development of new strategies for SLE treatment. Aim. This study aimed to determine the fecal microbiota profile in newly diagnosed SLE patients compared to healthy subjects and to investigate the correlation of this profile with disease activity. Methods. Newly diagnosed SLE patients who fulfilled at least four of the American College of Rheumatology (ACR) criteria were enrolled during the study period. Patients with lupus were matched to healthy subjects. SLE activity was evaluated using the Systemic Lupus Disease Activity Index (SLEDAI-2K). Fresh fecal samples were collected from each subject. Genomic DNA was extracted from fecal samples. Quantitative real-time PCR was applied for quantitation of Firmicutes phylum, Bacteroidetes phylum, and Lactobacillus genus in comparison to the total fecal microbiota. Results of patients’ samples were compared to those of healthy subjects and were correlated to patients’ SLEDAI-2K score. Results. Twenty SLE patients’ samples were compared with 20 control samples. There was a significant alteration in SLE patients’ gut microbiota. A significantly lower ( ) Firmicutes/Bacteroidetes (F/B) ratio in SLE patients (mean ratio: 0.66%) compared to healthy subjects (mean ratio: 1.79%) was found. Lactobacillus showed a significant decrease in SLE patients ( ) in comparison to healthy controls. An inverse significant correlation between SLEDAI-2K scores for disease activity and F/B ratio (r = −0.451; ) was found. However, an inverse nonsignificant correlation between SLEDAI-2K scores for disease activity and Lactobacillus (r = −0.155; ) was detected. Conclusion. Compared to healthy controls, recently diagnosed SLE Egyptian patients have an altered fecal microbiota profile with significant lowering of both F/B ratio and Lactobacillus abundance, which is weakly correlated with disease activity.
- Open Access
- 24 June 2021
- Published by Springer Nature in Egyptian Rheumatology and Rehabilitation
- Vol. 48 (1) , 1-11
Impact of home exercise program on self-efficacy and quality of life among primary knee osteoarthritis patients: a randomized controlled clinical study
Background: Knee osteoarthritis (KOA) is a common joint disorder in elderly individuals, causing pain, loss of physical functioning, disability, and reduction of life quality. Home exercise programs (HEP) serve as a crucial complement to outpatient rehabilitation therapy, as they save the cost of supervised physical therapy sessions, while also offering a high level of treatment. The aim of this study was to evaluate the effectiveness of the 6-month HEP on pain, quality of life, and self-efficacy in patients with primary KOA and to identify the adherence level to exercises and associations with patients’ characteristics and clinical outcomes. Results: After 6 months of HEP, there were statistically significant differences between groups for self-efficacy (p ≤ 0.001, from 58.29 to 71.5) (p = 0.23, from 55.98 to 57.72), quality of life (p ≤0.001, from 60.1 to 72.2) (p = 0.074, from 60.35 to 60.92), and pain severity (P ≤0.001, from 58.29 to 41.4) (P = 0.88, from 61.2 to 60.9) in favor of exercise group. Conclusions: Home-based exercise program improves pain score, self-efficacy, and quality of life in patients with knee osteoarthritis. Adherence level to the exercise program may have a positive impact on patient improvement.
- 24 June 2021
- Published by Springer Nature in Egyptian Rheumatology and Rehabilitation
- Vol. 48 (1) , 1-11
Open AccessImpact of home exercise program on self-efficacy and quality of life among primary knee osteoarthritis patients: a randomized controlled clinical study
Background: Knee osteoarthritis (KOA) is a common joint disorder in elderly individuals, causing pain, loss of physical functioning, disability, and reduction of life quality. Home exercise programs (HEP) serve as a crucial complement to outpatient rehabilitation therapy, as they save the cost of supervised physical therapy sessions, while also offering a high level of treatment. The aim of this study was to evaluate the effectiveness of the 6-month HEP on pain, quality of life, and self-efficacy in patients with primary KOA and to identify the adherence level to exercises and associations with patients’ characteristics and clinical outcomes. Results: After 6 months of HEP, there were statistically significant differences between groups for self-efficacy (p ≤ 0.001, from 58.29 to 71.5) (p = 0.23, from 55.98 to 57.72), quality of life (p ≤0.001, from 60.1 to 72.2) (p = 0.074, from 60.35 to 60.92), and pain severity (P ≤0.001, from 58.29 to 41.4) (P = 0.88, from 61.2 to 60.9) in favor of exercise group. Conclusions: Home-based exercise program improves pain score, self-efficacy, and quality of life in patients with knee osteoarthritis. Adherence level to the exercise program may have a positive impact on patient improvement.